Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NCATS Parallel Artificial Membrane Permeability Assay (PAMPA) - Blood-Brain Barrier (BBB) Permeability Screen
Assay data:267 Active, 438 Tested
SummaryCompounds, ActivePubMed Citation
Primary qHTS to identify inhibitors of SARS-CoV-2 cell entry
Assay data:368 Active, 78 Activity ≤ 1 µM, 5114 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Depositor
Cytotoxicity counterscreen for inhibitors of SARS-CoV-2 cell entry
Assay data:158 Active, 29 Activity ≤ 1 µM, 5114 Tested
Primary qHTS for Vero E6 cytotoxicity: counterscreen for inhibitors of SARS-S pseudo-typed particle cell entry
Assay data:20 Active, 14 Activity ≤ 1 µM, 2678 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Depositor
Primary qHTS for inhibitors of MERS-S pseudo-typed particle cell entry
Assay data:88 Active, 17 Activity ≤ 1 µM, 2678 Tested
Primary qHTS for Huh7 cytotoxicity: counterscreen for inhibitors of MERS-S pseudotyped particle cell entry
Assay data:25 Active, 8 Activity ≤ 1 µM, 2678 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on